Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN2 | P17706 | 7/20 | 1.00 |
| ▸ | PTPN1 | P18031 | 7/20 | 1.00 |
| ▸ | F3 | P13726 | 3/20 | 1.00 |
| ▸ | PNLIP | P16233 | 1/20 | 1.00 |
| ▸ | NOS2 | P35228 | 1/20 | 1.00 |
| ▸ | CES1 | P23141 | 4/20 | 0.76 |
| ▸ | CES2 | O00748 | 2/20 | 0.76 |
| ▸ | RELA | Q04206 | 3/20 | 0.72 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.72 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.72 |
| ▸ | POLB | P06746 | 3/20 | 0.71 |
| ▸ | AKR1B10 | O60218 | 3/20 | 0.71 |
| ▸ | GPBAR1 | Q8TDU6 | 3/20 | 0.71 |
| ▸ | PSMB11 | A5LHX3 | 2/20 | 0.71 |
| ▸ | PSMA7 | O14818 | 2/20 | 0.71 |
| ▸ | PLA2G1B | P04054 | 2/20 | 0.71 |
| ▸ | PTPRC | P08575 | 2/20 | 0.71 |
| ▸ | PTPRF | P10586 | 2/20 | 0.71 |
| ▸ | PSMB1 | P20618 | 2/20 | 0.71 |
| ▸ | ACP1 | P24666 | 2/20 | 0.71 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Oleanonic Acid SCHEMBL18687844 | 1.00 | PTPN2 (1.00) | PTPN2PTPN1F3PNLIPNOS2 | |
| Oleanonic Acid SCHEMBL18688313 | 1.00 | PTPN2 (1.00) | PTPN2PTPN1F3PNLIPNOS2 | |
| Oleanonic Acid SCHEMBL2762433 | 1.00 | PTPN2 (1.00) | PTPN2PTPN1F3PNLIPNOS2 | |
| Oleanonic Acid SCHEMBL16175546 | 1.00 | PTPN2 (1.00) | PTPN2PTPN1F3PNLIPNOS2 | |
| Oleanonic Acid SCHEMBL12200334 | 1.00 | PTPN2 (1.00) | PTPN2PTPN1F3PNLIPNOS2 | |
| Oleanonic Acid SCHEMBL12337276 | 1.00 | PTPN2 (1.00) | PTPN2PTPN1F3PNLIPNOS2 | |
| Oleanonic Acid SCHEMBL6898284 | 1.00 | PTPN2 (1.00) | PTPN2PTPN1F3PNLIPNOS2 | |
| Oleanonic Acid SCHEMBL12313105 | 1.00 | PTPN2 (1.00) | PTPN2PTPN1F3PNLIPNOS2 | |
| SCHEMBL17166004 | 0.92 | PTPN1 (0.85) | PTPN2PTPN1F3PNLIPNOS2 | |
| SCHEMBL16152971 | 0.89 | PTPN1 (0.81) | PTPN2PTPN1F3PNLIPNOS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 457 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4731172-A2 | COSMETIC COMPOSITION COMPRISING AT LEAST ONE NATURAL RESIN AND A CRYSTALLIZABLE FATTY SUBSTANCE | L'OREAL (FR) | 2026-04-29 | — | — | EP | claimed |
| EP-4551300-A1 | COSMETIC COMPOSITION COMPRISING A NATURAL RESIN | L'OREAL (FR) | 2025-05-14 | — | — | EP | claimed |
| US-20250064716-A1 | COSMETIC COMPOSITION COMPRISING A NATURAL RESIN | L'OREAL (FR) | 2025-02-27 | — | — | US | claimed |
| WO-2024261287-A2 | COSMETIC COMPOSITION COMPRISING AT LEAST ONE NATURAL RESIN AND A CRYSTALLIZABLE FATTY SUBSTANCE | L'OREAL (FR) | 2024-12-26 | — | — | WO | claimed |
| EP-4452200-A1 | COSMETIC COMPOSITION COMPRISING A NATURAL RESIN | L'OREAL (FR) | 2024-10-30 | — | — | EP | claimed |
| WO-2024008771-A1 | COSMETIC COMPOSITION COMPRISING A NATURAL RESIN | L'OREAL (FR) | 2024-01-11 | — | — | WO | claimed |
| WO-2024008772-A1 | COSMETIC COMPOSITION COMPRISING A NATURAL RESIN | L'OREAL (FR) | 2024-01-11 | — | — | WO | claimed |
| WO-2024008769-A1 | COSMETIC COMPOSITION COMPRISING A NATURAL RESIN | L'OREAL (FR) | 2024-01-11 | — | — | WO | claimed |
| WO-2023118430-A1 | COSMETIC COMPOSITION COMPRISING A NATURAL RESIN | L'OREAL (FR) | 2023-06-29 | — | — | WO | claimed |
| US-20230012268-A1 | COMPOSITIONS AND METHODS FOR TREATMENT OF INFLAMMATION WITH STEROIDS AND A MODULATOR | BUZZELET DEVELOPMENT AND TECHNOLOGIES LTD (IL) | 2023-01-12 | — | — | US | claimed |
| US-20130172416-A1 | COMPOSITIONS COMPRISING ACIDIC EXTRACTS OF MASTIC GUM | REGENERA PHARMA LTD. (IL) | 2013-07-04 | — | — | US | claimed |
| WO-2013101719-A2 | AMOORANIN COMPOUNDS AND ANALOGS THEREOF AND RELATED METHODS OF USE | NORTHEAST OHIO MEDICAL UNIVERSITY (US) | 2013-07-04 | — | — | WO | claimed |
| CN-103167871-A | Composition comprising an acidic extract of mastic gum | REGENERA PHARMA LTD | 2013-06-19 | — | — | CN | claimed |
| CN-103013631-A | Lubrication ointment | NANTONG HUADONG HYDRAULIC & LUBRICATE EQUIPMENT CO LTD | 2013-04-03 | — | — | CN | claimed |
| WO-2012032523-A9 | COMPOSITIONS COMPRISING ACIDIC EXTRACTS OF MASTIC GUM | REGENERA PHARMA LTD. (IL) | 2012-05-03 | — | — | WO | claimed |
| WO-2012032523-A2 | COMPOSITIONS COMPRISING ACIDIC EXTRACTS OF MASTIC GUM | REGENERA PHARMA LTD. (IL) | 2012-03-15 | — | — | WO | claimed |
| US-20050238740-A1 | Use of mastic and its components for the control of microbial infections | THALLIUM HOLDING COMPANY, LLC | 2005-10-27 | — | — | US | claimed |
| EP-1501527-A1 | USE OF MASTIC AND ITS COMPONENTS FOR THE CONTROL OF MICROBIAL INFECTIONS | LAVIPHARM S.A. (GR) | 2005-02-02 | — | — | EP | claimed |
| WO-2003092712-A1 | USE OF MASTIC AND ITS COMPONENTS FOR THE CONTROL OF MICROBIAL INFECTIONS | LAVIPHARM S.A. (GR) | 2003-11-13 | — | — | WO | claimed |
| CN-1380302-A | Triterpene compound concentrate | UNILEVER NV (NL) | 2002-11-20 | — | — | CN | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250064716-A1 | COSMETIC COMPOSITION COMPRISING A NATURAL RESIN | KRT18, CUTA, RARA | PTPN2 3309/4885PTPN1 3253/4885F3 698/4885 |
| US-20050238740-A1 | Use of mastic and its components for the control of microbial infections | CD14, RPL5, NFATC1 | PTPN2 2875/4885PTPN1 2641/4885F3 1982/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.